(INS) Lyxor - Lyxor STOXX Europe - Ratings and Ratios
Financial, Services, Insurance, Shares, ETF
Description: INS Lyxor - Lyxor STOXX Europe
The Lyxor STOXX Europe 600 Insurance UCITS ETF is an exchange-traded fund that tracks the performance of insurance companies listed in Europe, providing investors with exposure to the European insurance sector. As a Sector Equity Financial Services ETF, it is designed to give investors a targeted investment in this specific area of the financial services industry.
The funds underlying index is related to the Morningstar Global Financial Services sector, indicating its focus on financial services companies, although it specifically tracks the STOXX Europe 600 Insurance index. This suggests a concentrated investment in insurance companies within the broader European financial services landscape.
From a technical analysis perspective, the ETFs price action indicates a bullish trend, with the short-term and long-term moving averages (SMA20, SMA50, SMA200) all pointing upwards, suggesting a sustained increase in value. The Average True Range (ATR) of 1.62, or 1.95%, indicates moderate volatility, which is relatively contained and may appeal to investors seeking to manage risk. Given the current price is near its 52-week high, and considering the upward trend indicated by the moving averages, a potential forecast could be that the ETF continues to rise, potentially testing new highs.
Combining technical and fundamental analysis, with the Assets Under Management (AUM) standing at 60.39M EUR, the fund has a solid base of investor support. The upward trend in the ETFs price, coupled with its focus on the European insurance sector, suggests that investors are optimistic about the sectors prospects. If the European insurance sector continues to grow or stabilize, this could bode well for the ETFs future performance.
Forecasting future performance based on both technical and fundamental data, if the trend continues and the sector remains favorable, the Lyxor STOXX Europe 600 Insurance UCITS ETF could potentially reach new highs, possibly exceeding its current 52-week high of 83.37. However, its crucial to monitor both the technical indicators for signs of reversal and fundamental changes in the insurance sector that could impact the ETFs performance.
Additional Sources for INS ETF
INS ETF Overview
Market Cap in USD | 71m |
Category | Sector Equity Financial Services |
TER | 0.30% |
IPO / Inception | 2016-12-13 |
INS ETF Ratings
Growth Rating | 91.4 |
Fundamental | - |
Dividend Rating | 4.82 |
Rel. Strength | -0.3 |
Analysts | - |
Fair Price Momentum | 86.51 EUR |
Fair Price DCF | - |
INS Dividends
Currently no dividends paidINS Growth Ratios
Growth Correlation 3m | 35.2% |
Growth Correlation 12m | 96.3% |
Growth Correlation 5y | 95.9% |
CAGR 5y | 17.28% |
CAGR/Max DD 5y | 0.94 |
Sharpe Ratio 12m | 2.55 |
Alpha | 19.69 |
Beta | 0.418 |
Volatility | 13.82% |
Current Volume | 0.6k |
Average Volume 20d | 1.1k |
As of July 07, 2025, the stock is trading at EUR 80.95 with a total of 581 shares traded.
Over the past week, the price has changed by +0.07%, over one month by -3.26%, over three months by +15.96% and over the past year by +29.93%.
Yes. Based on ValueRay's Analyses, Lyxor - Lyxor STOXX Europe (PA:INS) is currently (July 2025) a good stock to buy. It has a ValueRay Growth Rating of 91.41 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of INS is around 86.51 EUR . This means that INS is currently overvalued and has a potential downside of 6.87%.
Lyxor - Lyxor STOXX Europe has no consensus analysts rating.
According to our own proprietary Forecast Model, INS Lyxor - Lyxor STOXX Europe will be worth about 96.4 in July 2026. The stock is currently trading at 80.95. This means that the stock has a potential upside of +19.1%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 96.4 | 19.1% |